South Africa’s medicines regulator is under mounting pressure from pharmaceutical manufacturers. This comes after it signalled it may phase out oral phenylephrine in over-the-counter (OTC) cold and flu medicines. The South African Health Products Regulatory Authority (SAHPRA) says the concern is simple: the ingredient may not work as a nasal decongestant when taken by mouth. Phenylephrine still appears in long-standing…